To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
36 Current news of Evonikrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
On 22 December, 2010, Evonik Industries and Boehringer Ingelheim Pharma GmbH & Co. KG signed an agreement on the sale of the Resomer® business to Evonik. The completion of the transaction is subject to various conditions and closing is expected early March 2011. Under the agreement, the entire ...
The Pharma Polymers business line, part of Evonik Röhm GmbH, a subsidiary of Evonik Industries AG, will implement price increases for its methyl methacrylate-based polymers for pharmaceutical applications by up to 12% for their global EUDRAGIT® business, effective January 1, 2011. The company’s ...
The Enzymicals AG gained proprietary rights for the well-known recombinant pig liver esterases (PLE) from Evonik AG in Hanau. The intellectual property (IP) covers a range of PLE isoenzymes for hydrolysis of several compounds such as esters of secondary and tertiary alcohols, lactones and ...
Evonik Industries is broadening its commitment in China: The company has started up a production plant for active pharmaceutical ingredients. It will supply the Chinese market, among others, and has a capacity of 70 cubic meters that can be doubled if required. The plant, in the city of Nanning ...
Evonik acquires Eli Lilly and Company’s U.S. Tippecanoe manufacturing site
Evonik Industries AG has agreed to acquire Indianapolis, Indiana-based Eli Lilly and Company’s Tippecanoe Laboratories manufacturing facility in Lafayette, Indiana. The site, which employs about 700, manufactures active pharmaceutical ingredients (API) and precursor materials for the ...
Possibilities and opportunities are far from exhausted
White biotechnology is becoming a major driver of growth and innovation in the chemical industry of the 21st century. This was the assessment recently made by one of Evonik Industries’ largest professional conferences on white biotechnology in Marl. The event, Bio Business Perspectives, brought ...